カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の動物用狂犬病ワクチン市場2022年：注射用ワクチン、経口ワクチン

◆英語タイトル：Global Animal Rabies Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8729 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：99 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥501,120	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥751,680	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,002,240	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

動物用狂犬病ワクチンは、狂犬病ウイルスに対する免疫を獲得するために動物に接種されるワクチンです。狂犬病は、主に感染した動物の唾液を介して広がる致死的なウイルス感染症であり、特に犬が主要な感染源となります。犬をはじめとする動物が感染すると、ヒトを含む他の動物にも感染する危険性があります。このため、動物用狂犬病ワクチンは、動物と人間の両方を守る重要な手段とされています。

狂犬病ウイルスは、ラビウイルス科に属するRNAウイルスで、感染の進行に伴い、神経系に深刻な影響を与えます。感染した動物は、徐々に症状が現れてきます。初期には、行動の変化や興奮が見られ、進行すると、麻痺や昏睡、最終的には死亡に至ることがほとんどです。したがって、狂犬病は人間にとっても感染症の一つであり、特に犬に対するワクチン接種が重要になります。

動物用狂犬病ワクチンは、いくつかの特徴を持っています。まず、ウイルスに対する免疫反応を誘発するために、弱毒化されたウイルスや不活化されたウイルスを含むことがあります。これにより、接種した動物が安全に免疫を獲得することが可能です。さらに、多くのワクチンは、接種後数週間で抗体を産生することが期待され、動物が狂犬病ウイルスに暴露された場合に即座に防御反応を発揮できるようになります。

動物用狂犬病ワクチンには、大きく分けて二つのタイプがあります。一つは、ウイルスが不活化された形式のワクチンで、主に健康な動物に接種されます。このタイプのワクチンは、安全性が高く、明確に決められた接種スケジュールに従って使われます。もう一つは、弱毒化された生ワクチンで、これは細菌やウイルスの強い反応が求められるシチュエーションで使用されることがあり、抗体を迅速に生成する効果があります。

狂犬病ワクチンの用途は主に動物の予防接種ですが、これにより人間の健康も守ることができます。特に狂犬病の流行がある地域では、犬を中心に広範囲にワクチン接種を行うことが、伝染症の予防において非常に重要です。国によっては、犬の登録や狂犬病ワクチン接種を法律で義務付けているところもあり、このような対策を通じて、ウイルスの拡散を避けることが目的とされています。

最近では、関連技術の進歩により、動物用狂犬病ワクチンの製造および評価手法が多様化しています。ワクチンの効果を向上させるためには、接種対象動物の年齢や健康状態、接種のタイミング、そして地域の狂犬病の流行状況などを考慮する必要があります。現代の技術によって、抗体の測定や反応の評価も行いやすくなっており、より効率的な予防策が実現されています。

また、アウトブレイク時の対応として、ワクチン接種の実施に加え、動物の追跡観察や感染動物の隔離などが必要です。こうした関連技術や資源は、狂犬病撲滅に向けた重要な要素となっています。効果的なワクチンプログラムを提供することで、動物の健康と人間の安全が守られるのです。

狂犬病ワクチンは、野生動物への接種も考慮されています。特に、野生の動物、たとえばコウモリやキツネなどが狂犬病ウイルスの保有者となることがあり、これらの動物に対するワクチン接種によって人間感染のリスクをさらに低減することができます。最近では、空中散布による生物学的ワクチンを使用する試みも行われています。

狂犬病は予防が可能な病気であり、動物用狂犬病ワクチンの使用はその最も効果的な方法と言えます。そのため、獣医師や動物飼育者、保健当局が協力し、広報活動や教育を通じて、狂犬病の認識を高めることが重要です。狂犬病ワクチンの接種は、単なる医学的処置だけではなく、動物の健康管理、社会の安全、そして人間の生命を守るための必須の取り組みとなります。

このように、動物用狂犬病ワクチンは、狂犬病ウイルスから動物を守るだけでなく、人間の健康を守る重要な役割を果たしています。感染症に対する予防策とその実施がどれほど大切であるかを理解し、正しい知識を持つことが、狂犬病の撲滅に向けた一歩となるでしょう。したがって、狂犬病ワクチンに関する啓発活動や予防接種は、今後も重要な課題であり、さらなる研究と技術の発展が期待されています。

動物用狂犬病ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の動物用狂犬病ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

動物用狂犬病ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・注射用ワクチン、経口ワクチン

用途別セグメントは次のように区分されます。
・ペット、野生動物

世界の動物用狂犬病ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Fort Dodge、Boehringer Ingelheim、Pfizer、CE-VA、Virbac、Schering-Plough、Bayer、Merck、Novartis

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、動物用狂犬病ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な動物用狂犬病ワクチンメーカーの企業概要、2019年～2022年までの動物用狂犬病ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な動物用狂犬病ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別動物用狂犬病ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの動物用狂犬病ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での動物用狂犬病ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および動物用狂犬病ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、動物用狂犬病ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Fort Dodge、Boehringer Ingelheim、Pfizer、CE-VA、Virbac、Schering-Plough、Bayer、Merck、Novartis
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：注射用ワクチン、経口ワクチン
・用途別分析2017年-2028年：ペット、野生動物
・動物用狂犬病ワクチンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・動物用狂犬病ワクチンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・動物用狂犬病ワクチンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・動物用狂犬病ワクチンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・動物用狂犬病ワクチンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Animal Rabies Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Animal Rabies Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pet accounting for % of the Animal Rabies Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inject Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Animal Rabies Vaccine include Fort Dodge, Boehringer Ingelheim, Pfizer, CE-VA, and Virbac, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Animal Rabies Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inject Vaccine
Oral Vaccine
Market segment by Application can be divided into
Pet
Wild Animals
The key market players for global Animal Rabies Vaccine market are listed below:
Fort Dodge
Boehringer Ingelheim
Pfizer
CE-VA
Virbac
Schering-Plough
Bayer
Merck
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal Rabies Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal Rabies Vaccine, with price, sales, revenue and global market share of Animal Rabies Vaccine from 2019 to 2022.
Chapter 3, the Animal Rabies Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal Rabies Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Animal Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Animal Rabies Vaccine.
Chapter 13, 14, and 15, to describe Animal Rabies Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Animal Rabies Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Animal Rabies Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inject Vaccine
1.2.3 Oral Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Animal Rabies Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pet
1.3.3 Wild Animals
1.4 Global Animal Rabies Vaccine Market Size & Forecast
1.4.1 Global Animal Rabies Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Animal Rabies Vaccine Sales in Volume (2017-2028)
1.4.3 Global Animal Rabies Vaccine Price (2017-2028)
1.5 Global Animal Rabies Vaccine Production Capacity Analysis
1.5.1 Global Animal Rabies Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Animal Rabies Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Rabies Vaccine Market Drivers
1.6.2 Animal Rabies Vaccine Market Restraints
1.6.3 Animal Rabies Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Fort Dodge
2.1.1 Fort Dodge Details
2.1.2 Fort Dodge Major Business
2.1.3 Fort Dodge Animal Rabies Vaccine Product and Services
2.1.4 Fort Dodge Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Animal Rabies Vaccine Product and Services
2.2.4 Boehringer Ingelheim Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Animal Rabies Vaccine Product and Services
2.3.4 Pfizer Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CE-VA
2.4.1 CE-VA Details
2.4.2 CE-VA Major Business
2.4.3 CE-VA Animal Rabies Vaccine Product and Services
2.4.4 CE-VA Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Animal Rabies Vaccine Product and Services
2.5.4 Virbac Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Schering-Plough
2.6.1 Schering-Plough Details
2.6.2 Schering-Plough Major Business
2.6.3 Schering-Plough Animal Rabies Vaccine Product and Services
2.6.4 Schering-Plough Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Animal Rabies Vaccine Product and Services
2.7.4 Bayer Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Animal Rabies Vaccine Product and Services
2.8.4 Merck Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Animal Rabies Vaccine Product and Services
2.9.4 Novartis Animal Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Animal Rabies Vaccine Breakdown Data by Manufacturer
3.1 Global Animal Rabies Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Animal Rabies Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Animal Rabies Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Animal Rabies Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Animal Rabies Vaccine Manufacturer Market Share in 2021
3.5 Global Animal Rabies Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Animal Rabies Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Animal Rabies Vaccine Market Size by Region
4.1.1 Global Animal Rabies Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Animal Rabies Vaccine Revenue by Region (2017-2028)
4.2 North America Animal Rabies Vaccine Revenue (2017-2028)
4.3 Europe Animal Rabies Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Animal Rabies Vaccine Revenue (2017-2028)
4.5 South America Animal Rabies Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Animal Rabies Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Animal Rabies Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Animal Rabies Vaccine Revenue by Type (2017-2028)
5.3 Global Animal Rabies Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Animal Rabies Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Animal Rabies Vaccine Revenue by Application (2017-2028)
6.3 Global Animal Rabies Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Animal Rabies Vaccine Sales by Type (2017-2028)
7.2 North America Animal Rabies Vaccine Sales by Application (2017-2028)
7.3 North America Animal Rabies Vaccine Market Size by Country
7.3.1 North America Animal Rabies Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Animal Rabies Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Animal Rabies Vaccine Sales by Type (2017-2028)
8.2 Europe Animal Rabies Vaccine Sales by Application (2017-2028)
8.3 Europe Animal Rabies Vaccine Market Size by Country
8.3.1 Europe Animal Rabies Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Animal Rabies Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Animal Rabies Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Animal Rabies Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Animal Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Animal Rabies Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Animal Rabies Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Animal Rabies Vaccine Sales by Type (2017-2028)
10.2 South America Animal Rabies Vaccine Sales by Application (2017-2028)
10.3 South America Animal Rabies Vaccine Market Size by Country
10.3.1 South America Animal Rabies Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Animal Rabies Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Animal Rabies Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Animal Rabies Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Animal Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Animal Rabies Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Animal Rabies Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Animal Rabies Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Animal Rabies Vaccine
12.3 Animal Rabies Vaccine Production Process
12.4 Animal Rabies Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Animal Rabies Vaccine Typical Distributors
13.3 Animal Rabies Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Animal Rabies Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Animal Rabies Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Fort Dodge Basic Information, Manufacturing Base and Competitors
Table 4. Fort Dodge Major Business
Table 5. Fort Dodge Animal Rabies Vaccine Product and Services
Table 6. Fort Dodge Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim Animal Rabies Vaccine Product and Services
Table 10. Boehringer Ingelheim Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Animal Rabies Vaccine Product and Services
Table 14. Pfizer Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CE-VA Basic Information, Manufacturing Base and Competitors
Table 16. CE-VA Major Business
Table 17. CE-VA Animal Rabies Vaccine Product and Services
Table 18. CE-VA Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Virbac Basic Information, Manufacturing Base and Competitors
Table 20. Virbac Major Business
Table 21. Virbac Animal Rabies Vaccine Product and Services
Table 22. Virbac Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 24. Schering-Plough Major Business
Table 25. Schering-Plough Animal Rabies Vaccine Product and Services
Table 26. Schering-Plough Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bayer Basic Information, Manufacturing Base and Competitors
Table 28. Bayer Major Business
Table 29. Bayer Animal Rabies Vaccine Product and Services
Table 30. Bayer Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Animal Rabies Vaccine Product and Services
Table 34. Merck Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Animal Rabies Vaccine Product and Services
Table 38. Novartis Animal Rabies Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Animal Rabies Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Animal Rabies Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Animal Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Animal Rabies Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Animal Rabies Vaccine Production Site of Key Manufacturer
Table 44. Animal Rabies Vaccine New Entrant and Capacity Expansion Plans
Table 45. Animal Rabies Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Animal Rabies Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Global Animal Rabies Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Global Animal Rabies Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Animal Rabies Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Animal Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Global Animal Rabies Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Global Animal Rabies Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Animal Rabies Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Animal Rabies Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Animal Rabies Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Animal Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Global Animal Rabies Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. Global Animal Rabies Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Animal Rabies Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Animal Rabies Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Animal Rabies Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Animal Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. North America Animal Rabies Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. North America Animal Rabies Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Animal Rabies Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Animal Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. North America Animal Rabies Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. North America Animal Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. North America Animal Rabies Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Europe Animal Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 71. Europe Animal Rabies Vaccine Sales by Country (2023-2028) & (K Units)
Table 72. Europe Animal Rabies Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Animal Rabies Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Animal Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Europe Animal Rabies Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Europe Animal Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Animal Rabies Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Animal Rabies Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Animal Rabies Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Animal Rabies Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Animal Rabies Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Animal Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Animal Rabies Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Animal Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Animal Rabies Vaccine Sales by Application (2023-2028) & (K Units)
Table 86. South America Animal Rabies Vaccine Sales by Country (2017-2022) & (K Units)
Table 87. South America Animal Rabies Vaccine Sales by Country (2023-2028) & (K Units)
Table 88. South America Animal Rabies Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Animal Rabies Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Animal Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. South America Animal Rabies Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. South America Animal Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. South America Animal Rabies Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Animal Rabies Vaccine Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Animal Rabies Vaccine Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Animal Rabies Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Animal Rabies Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Animal Rabies Vaccine Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Animal Rabies Vaccine Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Animal Rabies Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Animal Rabies Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Animal Rabies Vaccine Raw Material
Table 103. Key Manufacturers of Animal Rabies Vaccine Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Animal Rabies Vaccine Typical Distributors
Table 107. Animal Rabies Vaccine Typical Customers
List of Figures
Figure 1. Animal Rabies Vaccine Picture
Figure 2. Global Animal Rabies Vaccine Revenue Market Share by Type in 2021
Figure 3. Inject Vaccine
Figure 4. Oral Vaccine
Figure 5. Global Animal Rabies Vaccine Revenue Market Share by Application in 2021
Figure 6. Pet
Figure 7. Wild Animals
Figure 8. Global Animal Rabies Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Animal Rabies Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Animal Rabies Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Animal Rabies Vaccine Price (2017-2028) & (US$/Unit)
Figure 12. Global Animal Rabies Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Animal Rabies Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Animal Rabies Vaccine Market Drivers
Figure 15. Animal Rabies Vaccine Market Restraints
Figure 16. Animal Rabies Vaccine Market Trends
Figure 17. Global Animal Rabies Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Animal Rabies Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Animal Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Animal Rabies Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Animal Rabies Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Animal Rabies Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Animal Rabies Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Animal Rabies Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Animal Rabies Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Animal Rabies Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Animal Rabies Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Animal Rabies Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Animal Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Animal Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Animal Rabies Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Animal Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Animal Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Animal Rabies Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Animal Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Animal Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Animal Rabies Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Animal Rabies Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Animal Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Animal Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Animal Rabies Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Animal Rabies Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Animal Rabies Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Animal Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Animal Rabies Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Animal Rabies Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Animal Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Animal Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Animal Rabies Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Animal Rabies Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Animal Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Animal Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Animal Rabies Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Animal Rabies Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Animal Rabies Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Animal Rabies Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Animal Rabies Vaccine
Figure 77. Animal Rabies Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の動物用狂犬病ワクチン市場2022年：注射用ワクチン、経口ワクチン(Global Animal Rabies Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の動物用狂犬病ワクチン市場2022年：注射用ワクチン、経口ワクチン

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp